4893 items matching your search terms.

Prognostic and predictive values of primary vs secondary platinum resistance for bevacizumab treatment in platinum-resistant ovarian cancer in the AURELIA trial

Trillsch, F. Mahner, S. Hilpert, F. Davis, L. Garcia, E. Kristensen, G. Savarese, A. Vuylsteke, P. Loos, M. Zagouri, F. Gladieff, L. Sehouli, J. Lee, C. K. Gebski, V. Pujade-Lauraine, E.

Levator ani trauma and pelvic organ prolapse - a comparison of three translabial ultrasound scoring systems

Trutnovsky, G. Kamisan Atan, I. Ulrich, D. Martin, A. Dietz, H. P.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016     DOI:10.1111/aogs.13018

Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

Tseros, E. A. Gebski, V. Morgan, G. J. Veness, M. J.
ANNALS OF SURGICAL ONCOLOGY, 2016     DOI:10.1245/s10434-015-5070-6

HG-19 combined targeting of mitochondrial function and mTOR is a potent novel therapeutic approach for diffuse intrinsic pontine glioma

Tsoli, M. Chang, C. Shen, H. Liu, J. Chintranjan, A. Franshaw, .\L. Dilda, P. Carcaboso, A.M. Hogg, P. Ziegler, D.
, 2016     DOI:10.1093/neuonc/now073.16

Elucidating the Biological Mechanisms Linking Depressive Symptoms With Type 2 Diabetes in Men: The Longitudinal Effects of Inflammation, Microvascular Dysfunction, and Testosterone

Tully, P. J. Baumeister, H. Martin, S. Atlantis, E. Jenkins, A. Januszewski, A. O'Loughlin, P. Taylor, A. Wittert, G. A. Florey Adelaide Male Ageing, Study
PSYCHOSOMATIC MEDICINE, 2016     DOI:10.1097/PSY.0000000000000263

Engaging Future Clinical Oncology Researchers: An Initiative to Integrate Teaching of Biostatistics and Research Methodology into Specialty Training

Turner, S. Sundaresan, P. Mann, K. Pryor, D. Gebski, V. Shaw, T.
CLINICAL ONCOLOGY (ROYAL COLLEGE OF RADIOLOGISTS), 2016     DOI:10.1016/j.clon.2015.12.003

Infant feeding practices in infants at high risk of allergic disease

Valerio, C. Tan, J.W.L. Sertori, R. Barnes, E.H. Campbell, D.E.

Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion: an intergroup trial

Van Den Bent, M.J. Erridge, S. Vogelbaum, M.A. Nowak, A.K. Sanson, M. Brandes, A.A. Wick, W. Clement, P.M. Baurain, J.F. Mason, W.P. Chinot, O.L. Weller, M. Golfinopoulos, V. Aldape, K. Dinjens, W.N.M. Wesseling, P. Gorlia, T. Kros, J.M. Baumert, B.G.

Efficacy of a novel antibody-drug conjugate, ABT-414, as monotherapy in epidermal growth factor receptor amplified, recurrent glioblastoma

Van Den Bent, M.J. Gan, H.K. Lassman, A.B. Kumthekar, P. Merrell, R. Butowski, N.A. Lwin, Z. Mikkelsen, T. Nabors, L.B. Papadopoulos, K.P. Penas-Prado, M. Simes, J. Wheeler, H. Gomez, E.J. Lee, H.J. Roberts-Rapp, L. Xiong, H. Bain, E.E. Holen, K.D. Reardon, D.A.

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

van Hazel, G. A. Heinemann, V. Sharma, N. K. Findlay, M. P. Ricke, J. Peeters, M. Perez, D. Robinson, B. A. Strickland, A. H. Ferguson, T. Rodriguez, J. Kroning, H. Wolf, I. Ganju, V. Walpole, E. Boucher, E. Tichler, T. Shacham-Shmueli, E. Powell, A. Eliadis, P. Isaacs, R. Price, D. Moeslein, F. Taieb, J. Bower, G. Gebski, V. Van Buskirk, M. Cade, D. N. Thurston, K. Gibbs, P.
JOURNAL OF CLINICAL ONCOLOGY, 2016     DOI:10.1200/JCO.2015.66.1181

Survival and cardiotoxicity for patients with HER2 positive, metastatic breast cancer treated with trastuzumab in routine clinical practice

Vasista, A. Ryan, L. Wilcken, N. Moylan, E. Stockler, M. Kiely, B.

Characterizing patient-oriented tools that could be packaged with guidelines to promote self-management and guideline adoption: a meta-review

Vernooij, R. W. Willson, M. Gagliardi, A. R. members of the Guidelines International Network Implementation Working, Group
IMPLEMENTATION SCIENCE, 2016     DOI:10.1186/s13012-016-0419-1

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3

Vickers, M. M. Lee, C. Tu, D. Wheatley-Price, P. Parulekar, W. Brundage, M. D. Moore, M. J. Au, H. O'Callaghan, C. J. Jonker, D. J. Ringash, J. Goldstein, D.
PANCREATOLOGY, 2016     DOI:10.1016/j.pan.2016.08.013

Fenofibrate reduces uric acid levels and gout events in type 2 diabetes: results from the FIELD study

Waldman, B. Ansquer, J. C. Sullivan, D. Jenkins, A. McGill, N. Buizen, L. Feher, M. Foucher, C. Kesaniemi, A. Flack, J. D'Emden, M. Hedley, J. Keech, A.

Patient Education and Choice of Peritoneal Dialysis

Walker, R. C. Howard, K. Morton, R. L.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016     DOI:10.1053/j.ajkd.2016.06.007